메뉴 건너뛰기




Volumn 193, Issue 4, 2014, Pages 1920-1930

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT SYSTEM AS01 VACCINE; GLAXOSMITHKLINE; IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MPL; QS 21; UNCLASSIFIED DRUG; VACCINE;

EID: 84905964211     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400948     Document Type: Article
Times cited : (202)

References (55)
  • 1
    • 77958498224 scopus 로고    scopus 로고
    • Vaccine adjuvants: Putting innate immunity to work
    • Coffman, R. L. , A. Sher, and R. A. Seder. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
    • (2010) Immunity , vol.33 , pp. 492-503
    • Coffman, R.L.1    Sher, A.2    Seder, R.A.3
  • 2
    • 79955086319 scopus 로고    scopus 로고
    • Recent clinical experience with vaccines using MPL-and QS-21?containing adjuvant systems
    • Garçon, N. , and M. Van Mechelen. 2011. Recent clinical experience with vaccines using MPL-and QS-21?containing adjuvant systems. Expert Rev. Vaccines 10: 471-486.
    • (2011) Expert Rev. Vaccines , vol.10 , pp. 471-486
    • Garçon, N.1    Van Mechelen, M.2
  • 6
    • 79955079057 scopus 로고    scopus 로고
    • Monophosphoryl lipid A and synthetic lipid A mimetics in TLR4-based adjuvants and immunomodulators
    • C. J. Hackett, and D. A. Harn, Jr. , eds. Humana Press Inc. , Totowa, NJ
    • Baldridge, J. R. , K. Myers, D. Johnson, D. Persing, C. Cluff, and R. Hershberg. 2008. Monophosphoryl lipid A and synthetic lipid A mimetics in TLR4-based adjuvants and immunomodulators. In Vaccine Adjuvants: Immunological and Clinical Principles. C. J. Hackett, and D. A. Harn, Jr. , eds. Humana Press Inc. , Totowa, NJ, p. 235-255.
    • (2008) Vaccine Adjuvants: Immunological and Clinical Principles , pp. 235-255
    • Baldridge, J.R.1    Myers, K.2    Johnson, D.3    Persing, D.4    Cluff, C.5    Hershberg, R.6
  • 10
    • 0026033441 scopus 로고
    • Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex
    • Kensil, C. R. , U. Patel, M. Lennick, and D. Marciani. 1991. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146: 431-437.
    • (1991) J. Immunol , vol.146 , pp. 431-437
    • Kensil, C.R.1    Patel, U.2    Lennick, M.3    Marciani, D.4
  • 11
    • 79955112512 scopus 로고    scopus 로고
    • Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
    • Ragupathi, G. , J. R. Gardner, P. O. Livingston, and D. Y. Gin. 2011. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. Expert Rev. Vaccines 10: 463-470.
    • (2011) Expert Rev. Vaccines , vol.10 , pp. 463-470
    • Ragupathi, G.1    Gardner, J.R.2    Livingston, P.O.3    Gin, D.Y.4
  • 12
    • 0031661414 scopus 로고    scopus 로고
    • QS-21: A water-soluble triterpene glycoside adjuvant
    • Kensil, C. R. , and R. Kammer. 1998. QS-21: a water-soluble triterpene glycoside adjuvant. Expert Opin. Investig. Drugs 7: 1475-1482.
    • (1998) Expert Opin. Investig. Drugs , vol.7 , pp. 1475-1482
    • Kensil, C.R.1    Kammer, R.2
  • 13
    • 0028800377 scopus 로고
    • Structure/function studies of QS-21 adjuvant: Assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function
    • Soltysik, S. , J. Y. Wu, J. Recchia, D. A. Wheeler, M. J. Newman, R. T. Coughlin, and C. R. Kensil. 1995. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13: 1403-1410.
    • (1995) Vaccine , vol.13 , pp. 1403-1410
    • Soltysik, S.1    Wu, J.Y.2    Recchia, J.3    Wheeler, D.A.4    Newman, M.J.5    Coughlin, R.T.6    Kensil, C.R.7
  • 14
    • 0028171987 scopus 로고
    • Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
    • Livingston, P. O. , S. Adluri, F. Helling, T. J. Yao, C. R. Kensil, M. J. Newman, and D. Marciani. 1994. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 12: 1275-1280.
    • (1994) Vaccine , vol.12 , pp. 1275-1280
    • Livingston, P.O.1    Adluri, S.2    Helling, F.3    Yao, T.J.4    Kensil, C.R.5    Newman, M.J.6    Marciani, D.7
  • 15
    • 63149151276 scopus 로고    scopus 로고
    • ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II
    • Schnurr, M. , M. Orban, N. C. Robson, A. Shin, H. Braley, D. Airey, J. Cebon, E. Maraskovsky, and S. Endres. 2009. ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. J. Immunol. 182: 1253-1259.
    • (2009) J. Immunol , vol.182 , pp. 1253-1259
    • Schnurr, M.1    Orban, M.2    Robson, N.C.3    Shin, A.4    Braley, H.5    Airey, D.6    Cebon, J.7    Maraskovsky, E.8    Endres, S.9
  • 16
    • 79960413988 scopus 로고    scopus 로고
    • ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells
    • Duewell, P. , U. Kisser, K. Heckelsmiller, S. Hoves, P. Stoitzner, S. Koernig, A. B. Morelli, B. E. Clausen, M. Dauer, A. Eigler, et al. 2011. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J. Immunol. 187: 55-63.
    • (2011) J. Immunol , Issue.187 , pp. 55-63
    • Duewell, P.1    Kisser, U.2    Heckelsmiller, K.3    Hoves, S.4    Stoitzner, P.5    Koernig, S.6    Morelli, A.B.7    Clausen, B.E.8    Dauer, M.9    Eigler, A.10
  • 19
    • 84859427365 scopus 로고    scopus 로고
    • Cell-mediated immune responses to a varicella-zoster virus glycoprotein e vaccine using both a TLR agonist and QS21 in mice
    • Dendouga, N. , M. Fochesato, L. Lockman, S. Mossman, and S. L. Giannini. 2012. Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine 30: 3126-3135.
    • (2012) Vaccine , vol.30 , pp. 3126-3135
    • Dendouga, N.1    Fochesato, M.2    Lockman, L.3    Mossman, S.4    Giannini, S.L.5
  • 21
    • 77957357557 scopus 로고    scopus 로고
    • Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
    • Leroux-Roels, I. , M. Koutsoukos, F. Clement, S. Steyaert, M. Janssens, P. Bourguignon, K. Cohen, M. Altfeld, P. Vandepapelière, L. Pedneault, et al. 2010. Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems. Vaccine 28: 7016-7024.
    • (2010) Vaccine , vol.28 , pp. 7016-7024
    • Leroux-Roels, I.1    Koutsoukos, M.2    Clement, F.3    Steyaert, S.4    Janssens, M.5    Bourguignon, P.6    Cohen, K.7    Altfeld, M.8    Vandepapelière, P.9    Pedneault, L.10
  • 22
    • 84875818500 scopus 로고    scopus 로고
    • Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
    • Leroux-Roels, I. , S. Forgus, B. F. De, F. Clement, M. A. Demoitie, P. Mettens, P. Moris, E. Ledent, G. Leroux-Roels, and O. Ofori-Anyinam. 2013. Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial. Vaccine 31: 2196-2206.
    • (2013) Vaccine , vol.31 , pp. 2196-2206
    • Leroux-Roels, I.1    Forgus, S.2    De, B.F.3    Clement, F.4    Demoitie, M.A.5    Mettens, P.6    Moris, P.7    Ledent, E.8    Leroux-Roels, G.9    Ofori-Anyinam, O.10
  • 23
    • 67650699591 scopus 로고    scopus 로고
    • Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: Safety, efficacy, and immunologic associates of protection
    • Kester, K. E. , J. F. Cummings, O. Ofori-Anyinam, C. F. Ockenhouse, U. Krzych, P. Moris, R. Schwenk, R. A. Nielsen, Z. Debebe, E. Pinelis, et al. 2009. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200: 337-346.
    • (2009) J. Infect. Dis , vol.200 , pp. 337-346
    • Kester, K.E.1    Cummings, J.F.2    Ofori-Anyinam, O.3    Ockenhouse, C.F.4    Krzych, U.5    Moris, P.6    Schwenk, R.7    Nielsen, R.A.8    Debebe, Z.9    Pinelis, E.10
  • 24
    • 84871666296 scopus 로고    scopus 로고
    • A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
    • Ndungu, F. M. , J. Mwacharo, D. Kimani, O. Kai, P. Moris, E. Jongert, J. Vekemans, A. Olotu, and P. Bejon. 2012. A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E. PLoS One 7: e52870.
    • (2012) PLoS One , vol.7
    • Ndungu, F.M.1    Mwacharo, J.2    Kimani, D.3    Kai, O.4    Moris, P.5    Jongert, E.6    Vekemans, J.7    Olotu, A.8    Bejon, P.9
  • 25
    • 80053602298 scopus 로고    scopus 로고
    • Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria
    • Olotu, A. , P. Moris, J. Mwacharo, J. Vekemans, D. Kimani, M. Janssens, O. Kai, E. Jongert, M. Lievens, A. Leach, et al. 2011. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria. PLoS One 6: e25786.
    • (2011) PLoS One , vol.6
    • Olotu, A.1    Moris, P.2    Mwacharo, J.3    Vekemans, J.4    Kimani, D.5    Janssens, M.6    Kai, O.7    Jongert, E.8    Lievens, M.9    Leach, A.10
  • 28
  • 29
    • 84856826706 scopus 로고    scopus 로고
    • CD64 expression distinguishes monocytederived and conventional dendritic cells and reveals their distinct role during intramuscular immunization
    • Langlet, C. , S. Tamoutounour, S. Henri, H. Luche, L. Ardouin, C. Grégoire, B. Malissen, and M. Guilliams. 2012. CD64 expression distinguishes monocytederived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 188: 1751-1760.
    • (2012) J. Immunol , Issue.188 , pp. 1751-1760
    • Langlet, C.1    Tamoutounour, S.2    Henri, S.3    Luche, H.4    Ardouin, L.5    Grégoire, C.6    Malissen, B.7    Guilliams, M.8
  • 32
    • 67649404131 scopus 로고    scopus 로고
    • Blood monocytes: Development, heterogeneity, and relationship with dendritic cells
    • Auffray, C. , M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
    • (2009) Annu. Rev. Immunol , vol.27 , pp. 669-692
    • Auffray, C.1    Sieweke, M.H.2    Geissmann, F.3
  • 36
    • 77958111199 scopus 로고    scopus 로고
    • Dynamics of dendritic cell?T cell interactions: A role in T cell outcome
    • Hugues, S. 2010. Dynamics of dendritic cell?T cell interactions: a role in T cell outcome. Semin. Immunopathol. 32: 227-238.
    • (2010) Semin. Immunopathol , Issue.32 , pp. 227-238
    • Hugues, S.1
  • 37
    • 19344376093 scopus 로고    scopus 로고
    • Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
    • Obst, R. , H. M. van Santen, D. Mathis, and C. Benoist. 2005. Antigen persistence is required throughout the expansion phase of a CD4+ T cell response. J. Exp. Med. 201: 1555-1565.
    • (2005) J. Exp. Med , vol.201 , pp. 1555-1565
    • Obst, R.1    Van Santen, H.M.2    Mathis, D.3    Benoist, C.4
  • 38
    • 84861963478 scopus 로고    scopus 로고
    • The mechanism of action of MF59-an innately attractive adjuvant formulation
    • O'Hagan, D. T. , G. S. Ott, E. De Gregorio, and A. Seubert. 2012. The mechanism of action of MF59-an innately attractive adjuvant formulation. Vaccine 30: 4341-4348.
    • (2012) Vaccine , vol.30 , pp. 4341-4348
    • O'Hagan, D.T.1    Ott, G.S.2    De Gregorio, E.3    Seubert, A.4
  • 42
    • 84867900263 scopus 로고    scopus 로고
    • HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
    • Girard, J. P. , C. Moussion, and R. Förster. 2012. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12: 762-773.
    • (2012) Nat. Rev. Immunol , Issue.12 , pp. 762-773
    • Girard, J.P.1    Moussion, C.2    Förster, R.3
  • 43
    • 0036681837 scopus 로고    scopus 로고
    • The CXC chemokine murine monokine induced by IFN-g (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo
    • Park, M. K. , D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al. 2002. The CXC chemokine murine monokine induced by IFN-g (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 169: 1433-1443.
    • (2002) J. Immunol , vol.169 , pp. 1433-1443
    • Park, M.K.1    Amichay, D.2    Love, P.3    Wick, E.4    Liao, F.5    Grinberg, A.6    Rabin, R.L.7    Zhang, H.H.8    Gebeyehu, S.9    Wright, T.M.10
  • 45
    • 78049413094 scopus 로고    scopus 로고
    • Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants
    • Yang, C. W. , B. S. Strong, M. J. Miller, and E. R. Unanue. 2010. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 185: 2927-2934.
    • (2010) J. Immunol , Issue.185 , pp. 2927-2934
    • Yang, C.W.1    Strong, B.S.2    Miller, M.J.3    Unanue, E.R.4
  • 46
    • 79952704589 scopus 로고    scopus 로고
    • Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
    • Calabro, S. , M. Tortoli, B. C. Baudner, A. Pacitto, M. Cortese, D. T. O'Hagan, E. De Gregorio, A. Seubert, and A. Wack. 2011. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29: 1812-1823.
    • (2011) Vaccine , vol.29 , pp. 1812-1823
    • Calabro, S.1    Tortoli, M.2    Baudner, B.C.3    Pacitto, A.4    Cortese, M.5    O'Hagan, D.T.6    De Gregorio, E.7    Seubert, A.8    Wack, A.9
  • 47
    • 79960829290 scopus 로고    scopus 로고
    • Neutrophils in the activation and regulation of innate and adaptive immunity
    • Mantovani, A. , M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
    • (2011) Nat. Rev. Immunol , Issue.11 , pp. 519-531
    • Mantovani, A.1    Cassatella, M.A.2    Costantini, C.3    Jaillon, S.4
  • 48
    • 34248997759 scopus 로고    scopus 로고
    • Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
    • Arnold, L. , A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
    • (2007) J. Exp. Med , vol.204 , pp. 1057-1069
    • Arnold, L.1    Henry, A.2    Poron, F.3    Baba-Amer, Y.4    Van Rooijen, N.5    Plonquet, A.6    Gherardi, R.K.7    Chazaud, B.8
  • 49
    • 77349089236 scopus 로고    scopus 로고
    • Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation
    • Domínguez, P. M. , and C. Ardavín. 2010. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234: 90-104.
    • (2010) Immunol. Rev , Issue.234 , pp. 90-104
    • Domínguez, P.M.1    Ardavín, C.2
  • 50
    • 62849119018 scopus 로고    scopus 로고
    • Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses
    • Nakano, H. , K. L. Lin, M. Yanagita, C. Charbonneau, D. N. Cook, T. Kakiuchi, and M. D. Gunn. 2009. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 10: 394-402.
    • (2009) Nat. Immunol , vol.10 , pp. 394-402
    • Nakano, H.1    Lin, K.L.2    Yanagita, M.3    Charbonneau, C.4    Cook, D.N.5    Kakiuchi, T.6    Gunn, M.D.7
  • 52
    • 84866489404 scopus 로고    scopus 로고
    • Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion
    • Soudja, S. M. , A. L. Ruiz, J. C. Marie, and G. Lauvau. 2012. Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37: 549-562
    • (2012) Immunity , vol.37 , pp. 549-562
    • Soudja, S.M.1    Ruiz, A.L.2    Marie, J.C.3    Lauvau, G.4
  • 53
    • 84871109342 scopus 로고    scopus 로고
    • Suppression of vaccine immunity by inflammatory monocytes
    • Mitchell, L. A. , A. J. Henderson, and S. W. Dow. 2012. Suppression of vaccine immunity by inflammatory monocytes. J. Immunol. 189: 5612-5621.
    • (2012) J. Immunol , Issue.189 , pp. 5612-5621
    • Mitchell, L.A.1    Henderson, A.J.2    Dow, S.W.3
  • 54
    • 47849087075 scopus 로고    scopus 로고
    • Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3
    • Li, H. , S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21.
    • (2008) J. Immunol , vol.181 , pp. 17-21
    • Li, H.1    Willingham, S.B.2    Ting, J.P.3    Re, F.4
  • 55
    • 39249083535 scopus 로고    scopus 로고
    • Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
    • Vandepapelière, P. , Y. Horsmans, P. Moris, M. Van Mechelen, M. Janssens, M. Koutsoukos, P. Van Belle, F. Clement, E. Hanon, M. Wettendorff, et al. 2008. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 26: 1375-1386.
    • (2008) Vaccine , vol.26 , pp. 1375-1386
    • Vandepapelière, P.1    Horsmans, Y.2    Moris, P.3    Van Mechelen, M.4    Janssens, M.5    Koutsoukos, M.6    Van Belle, P.7    Clement, F.8    Hanon, E.9    Wettendorff, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.